Rani has developed the RaniPill® capsule, which is a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with ...

Alvotech and Teva Pharmaceuticals announced that the U.S. FDA has approved a new presentation of SELARSDI™ (ustekinumab-aekn), a biosimilar to Stelara ® (ustekinumab), in a 130 mg/26 mL single-dose ...

Otsuka Holdings will pay ICU Medical an upfront payment of $200 million. The U.S. IV products market has seen ...

Monoclonal antibodies, oral therapies, and infusion treatments are among the most promising options and drives the multiple ...

Doctors say they've been forced to ration care as sourcing the essential medicine continues to prove a challenge.

Company to host conference call and webcast today at 8:30 a.m. EST CARMIEL, Israel, Nov. 14, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE-American: PLX), a biopharmaceutical company ...

Monoclonal antibodies, oral therapies, and infusion treatments are among the most promising options and drives the multiple sclerosis market. LAS VEGAS, Nov. 13, 2024 /PRNewswire/ -- DelveInsight's ...

As we delve into this collection of notable alcohol logos, we will uncover the strategic thinking and design principles behind them. Learn more here! A logo is the face of a brand, encapsulating its ...